# THE LOVESAC COMPANY (LOVE) · Edgar & Edgarette company card

> The Lovesac Company (LOVE) grew revenue 2.4% in FY2026 to $697 million, operating margin 0.8%, equity 40.9% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1701758 · fiscal year ended 2026-02-01 · 5 audited years read · [page](https://www.pops4.com/boards/company/LOVE) · [JSON](https://www.pops4.com/boards/company/LOVE.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $697M |
| Revenue growth, 1 year | 2.4% |
| Revenue growth per year | 8.7% |
| Operating margin | 0.8% (prior year 2.0%) |
| Net margin | 0.6% |
| Operating cash flow | $49M |
| Capital spending | $23M |
| Free cash flow | $26M |
| Cash | $102M |
| Long-term debt | — |
| Total assets | $535M |
| Total equity | $219M |
| Equity ÷ assets | 40.9% |
| Return on equity | 1.9% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 2.04 (grey zone)
- Piotroski F: 7 of 9 (solid)
- Beneish M: -3.09 (below the −1.78 line)
- Health Harbor boat: Weathered boat · two warning signs · slow and jumpy: growing slower than its size class, with revenue that swings more; revenue is hard to predict: its 80% range is ±26%
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $697.1M (FY2026). Experience: revenue up 2.4% on the year, up 8.7% a year over 4 years; operating margin 0.8%, down from 2.0%. Soundness: equity 40.9% of assets, return on equity 1.9%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $537.8M and $913.7M next year (method v4.1: its own 5-year record of growth weighed at 57% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $470.3M to $1.1B. A statistical range, not company guidance.

Range logged 2026-11-01, receipt 802668bacbce130a, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 2, latest 2026-06-15 ([filing](https://www.sec.gov/Archives/edgar/data/1701758/000121390026068869/0001213900-26-068869-index.htm))

## Recent filings

- 10-Q · filed 2026-09-10 · [filing](https://www.sec.gov/Archives/edgar/data/1701758/000162828026061220/0001628280-26-061220-index.htm)
- 8-K · filed 2026-09-10 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1701758/000162828026061219/0001628280-26-061219-index.htm)
- 8-K · filed 2026-06-15 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1701758/000121390026068869/0001213900-26-068869-index.htm)
- 10-Q · filed 2026-06-11 · [filing](https://www.sec.gov/Archives/edgar/data/1701758/000162828026042366/0001628280-26-042366-index.htm)
- 8-K · filed 2026-06-11 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1701758/000162828026042363/0001628280-26-042363-index.htm)
- 8-K · filed 2026-06-09 · 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1701758/000162828026041938/0001628280-26-041938-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001701758.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1701758

## Cite

POPS4, Edgar & Edgarette: THE LOVESAC COMPANY (LOVE) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/LOVE. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.